Replies to post #235231 on Biotech Values

[DewDiligence]

DHR acquires ABCM for $24/sh cash—a 3% premium to Friday’s close:

https://www.businesswire.com/news/home/20230828718642/en

The nominal deal value is $5.7B.

The explanation for such a small premium may be that the transaction terms leaked a few months ago when ABCM was trading at a much lower share price.